Sign in
8-K

Current Report

AMGEN INC Filed Acc 0001193125-14-384251

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading d811787d8k.htm…